| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910138449703321 |
|
|
Autore |
Kamoi Kyuzi |
|
|
Titolo |
Diabetes insipidus / / edited by Kyuzi Kamoi |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
IntechOpen, 2011 |
|
Rijeka, Croatia : , : InTech, , [2011] |
|
©2011 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (150 pages) |
|
|
|
|
|
|
Collana |
|
NIH publication ; ; no. 03-4620 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Title from title screen (viewed on Dec. 1, 2004). |
Caption title. |
"June 2003." |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
The first chapter of the book reports on the management of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus and its associated endocrinological/neurological sequelae in the national survey. The next chapter addresses DI and head injuries. Next, the management of neuroendocrine instability during maintenance of potential organ donors is described. Organ transplants have gradually increased worldwide. To have maintenance of appropriate potential organs, AVP is needed. Furthermore, nephrogenic DI-the potential therapeutic drugs and analysis of membrane protein stability is the topic of the next two chapters, followed by new insights into the diagnosis and management of pregnancy-related DI. The seventh chapter reports on the problems with differential diagnosis in a case of central DI in a female patient with bipolar disorder. The lithium treatment usually resulted in nephrogenic DI. Finally, over the last years, the development of MRI imaging on the pituitary gland with the stalk and hypothalamus has advanced. The final chapter interprets imaging techniques in DI in detail. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910484969603321 |
|
|
Titolo |
Cannabinoids and Neuropsychiatric Disorders / / edited by Eric Murillo-Rodriguez, S. R. Pandi-Perumal, Jaime M. Monti |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2021.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (XVII, 153 p. 43 illus., 4 illus. in color.) |
|
|
|
|
|
|
Collana |
|
Advances in Experimental Medicine and Biology, , 2214-8019 ; ; 1264 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Medicine - Research |
Biology - Research |
Neurosciences |
Biomedical Research |
Neuroscience |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues. Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (Δ9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among other effects. Despite these undesirable effects, signaling is mostly inhibitory and suggests a putative role for cannabinoids as therapeutic agents by managing several diseases where inhibition of neurotransmitter release would be beneficial. The themes of this book have been edited and written by world-leaders in the field, The contents of the volume aims at readers from a range of academic and professional disciplines, such as biomedicine, several areas of biology, neurology, clinical medicine and pharmacy. |
|
|
|
|
|
|
|
| |